LENZ Therapeutics (LENZ) announced that the U.S. Food and Drug Administration, FDA, has accepted the Company’s New Drug Application, NDA, ...

FDA sets Prescription Drug User Fee Act (PDUFA) target date of August 8, 2025SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a ...

(RTTNews) - LENZ Therapeutics, Inc. (LENZ) Monday said that the Food and Drug Administration (FDA) has accepted the company's new drug application for LNZ100 for the treatment of presbyopia.

LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.

LENZ Therapeutics said the submission for the treatment of presbyopia is supported by the positive data results from a Phase 3 study. Aceclidine is a new chemical entity in the U.S. and isn't approved ...

Lenz Therapeutics shares hit a new 52-week high during Monday's session. The company announced the FDA accepted its new drug ...

Inside the Last-Ditch Hunt by Harris and Trump for Undecided Voters Both campaigns think many of these crucial Americans are younger, Black or Latino. The Harris team is also eyeing white, college ...

With two weeks to go before the U.S. presidential election, cases of political violence have shown the biggest and most sustained increase since the 1970s. United Statescategory Nebraska ...

"We are essentially moving from a situation of defeating the enemy in all the contact villages to a state of destruction." Information ...

Shirel Golan had been battling a post-traumatic stress disorder following the Hamas massacre on October 7, 2023, before she took her own life, her brother Eyal Golan said. She was found dead in ...

His attendance at a Russian conference is a shocking step backwards less than three years since the UN condemned Moscow’s brutal invasion ...